Environmental agents involved in the cause of primary biliary cirrhosis

Disease Markers

Volumn 29, Issue 6, 2010, Pages 329-336

  Kouroumalis, Elias ^a  

^a UNIVERSITY OF CRETE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

2 NONYNOIC ACID; ESTROGEN; LAMIVUDINE; MITOCHONDRION ANTIBODY; OXOGLUTARATE DEHYDROGENASE; POTASSIUM CHANNEL BLOCKING AGENT; PYRUVATE DEHYDROGENASE COMPLEX; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; XENOBIOTIC AGENT; ZIDOVUDINE;

ABORTION; APPENDECTOMY; ARTICLE; B LYMPHOCYTE; BACTERIAL INFECTION; CHLAMYDIA; CHLAMYDOPHILA PNEUMONIAE; CHOLECYSTECTOMY; CROSS REACTION; DISEASE ASSOCIATION; ECTOPIC PREGNANCY; ENVIRONMENT; ESCHERICHIA COLI; FEMALE GENITAL SYSTEM; GRAM NEGATIVE BACTERIUM; HELICOBACTER INFECTION; HUMAN; INNATE IMMUNITY; KLEBSIELLA PNEUMONIAE; LIFESTYLE; MOLECULAR MIMICRY; MOUSE MAMMARY TUMOR ONCOVIRUS; MYCOBACTERIUM GORDONAE; NEISSERIA MENINGITIDIS; NEOPLASM; NONHUMAN; NOVOSPHINGOBIUM AROMATICIVORANS; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROTEUS MIRABILIS; RISK FACTOR; SALMONELLA MINNESOTA; SMOKING; STAPHYLOCOCCUS AUREUS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TONSILLECTOMY; TRYPANOSOMA BRUCEI; URINARY TRACT INFECTION; VAGINITIS; VIRUS EXPRESSION; VIRUS REPLICATION;

EID: 79951660902     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.3233/DMA-2010-0769     Document Type: Article

References (83)

1. K. Ohba, K. Omagari, H. Kinoshita et al., Primary biliary cirrhosis among atomic bomb survivors in nagasaki, japan, Journal of Clinical Epidemiology 54 (2001), 845-850. (Pubitemid 32722190)
2. T. Addison and W. Gull, On a certain affection of the skinvitiligoidea-plana-tuberosa, GuysHospRep 7 (1851), G265-G277.
3. E.H. Ahrens, Jr. and H.G. Kunkel, The relationship between serum lipids and skin xanthomata in 18 patients with primary biliary cirrhosis, The Journal of Clinical Investigation 28 (1949), 1565-1574.
4. M.E.Gershwin and I.R.Mackay, The causes of primary biliary cirrhosis: Convenient and inconvenient truths, Hepatology (Baltimore, Md 47 (2008), 737-745. (Pubitemid 351280742)
5. S. Hohenester, R.P. OudeElferink and U Beuers, Primary biliary cirrhosis, Seminars in Immunopathology 31 (2009), 283-307.
6. T. Kumagi and E.J. Heathcote, Primary biliary cirrhosis, Orphanet Journal of rare Diseases 3 (2008), 1.
7. C. Selmi, M.J. Mayo, N. Bach et al., Primary biliary cirrhosis in monozygotic and dizygotic twins: Genetics, epigenetics, and environment, Gastroenterology 127 (2004), 485-492. (Pubitemid 39091897)
8. P. Invernizzi, C. Selmi, I.R. Mackay, M. Podda and M.E. Gershwin, From bases to basis: Linking genetics to causation in primary biliary cirrhosis, Clin Gastroenterol Hepatol 3 (2005), 401-410. (Pubitemid 40616904)
9. J.A. Talwalkar and K.D. Lindor, Primary biliary cirrhosis, Lancet 362 (2003), 53-61. (Pubitemid 36835823)
10. C. Selmi, P. Invernizzi, E.B. Keeffe et al., Epidemiology and pathogenesis of primary biliary cirrhosis, Journal of Clinical Gastroenterology 38 (2004), 264-271. (Pubitemid 38233336)
11. S. AbuMouch, C. Selmi, G.D. Benson et al., Geographic clusters of primary biliary cirrhosis, Clinical&Developmental Immunology 10 (2003), 127-131. (Pubitemid 38089403)
12. M.I. Prince, A. Chetwynd, P. Diggle, M. Jarner, J.V. Metcalf and O.F. James, The geographical distribution of primary biliary cirrhosis in awelldefined cohort, Hepatology (Baltimore, Md 34 (2001), 1083-1088. (Pubitemid 33096579)
13. R.J. McNally, S. Ducker and O.F. James, Are transient environmental agents involved in the cause of primary biliary cirrhosis? Evidence from spacetime clustering analysis, Hepatology (Baltimore, Md 50 (2009), 1169-1174.
14. A. Ala, C.M. Stanca, M. BuGhanim et al, Increased prevalence of primary biliary cirrhosis near superfund toxic waste sites, Hepatology (Baltimore, Md 43 (2006), 525-531.
15. D.E Jones, Pathogenesis of primary biliary cirrhosis, Gut 56 (2007), 1615-1624.
16. A. Long, C. Quan, J. Van de Water et al., Immunoreactivity of organic mimeotopes of the e2 component of pyruvate dehydrogenase: Connecting xenobiotics with primary biliary cirrhosis, J Immunol 167 (2001), 2956-2963. (Pubitemid 32768932)
17. S.A. Long, J. Van de Water and M.E. Gershwin, Antimitochondrial antibodies in primary biliary cirrhosis: The role of xenobiotics, Autoimmunity Reviews 1 (2002), 37-42. (Pubitemid 38367423)
18. R. Rieger andM.E.Gershwin, The x and why of xenobiotics in primary biliary cirrhosis, Journal of Autoimmunity 28 (2007), 76-84. (Pubitemid 46680497)
19. C. Selmi and M.E. Gershwin, Bacteria and human autoimmunity: The case of primary biliary cirrhosis, Current Opinion in Rheumatology 16 (2004), 406-410. (Pubitemid 38803142)
20. A. ParikhPatel, E.B. Gold, H. Worman, K.E. Krivy and M.E. Gershwin, Risk factors for primary biliary cirrhosis in a cohort of patients from the united states, Hepatology (Baltimore, Md 33 (2001), 16-21. (Pubitemid 32016882)
21. M.E. Gershwin, C. Selmi, H.J. Worman et al, Risk factors and comorbidities in primary biliary cirrhosis: A controlled interviewbased study of 1032 patients, Hepatology (Baltimore, Md 42 (2005), 1194-1202. (Pubitemid 43112687)
22. O. James, S. Ducker and M. Prince, Case control studies support the association of environmental and genetic risk factors with primary biliary cirrhosis, Hepatology (Baltimore, Md 42 (Suppl 1) (2005), 209A.
23. N. AgmonLevin, B.S. Katz and Y. Shoenfeld, Infection and primary biliary cirrhosis, IsrMed Assoc J 11 (2009), 112-115.
24. P. Butler, F. Valle, J.M. HamiltonMiller, W. Brumfitt, H. Baum and A.K. Burroughs, M2 mitochondrial antibodies and urinary rough mutant bacteria in patients with primary biliary cirrhosis and in patients with recurrent bacteriuria, Journal of Hepatology 17 (1993), 408-414. (Pubitemid 23134941)
25. A. ParikhPatel, E. Gold, J. Utts and M.E. Gershwin, The association between gravidity and primary biliary cirrhosis, Annals of Epidemiology 12 (2002), 264-272. (Pubitemid 34428626)
26. J.M.Guattery andW.W. Faloon, Effect of estradiol upon serum enzymes in primary biliary cirrhosis, Hepatology (Baltimore, Md 7 (1987), 737-742. (Pubitemid 17130715)
27. C. Corpechot, Y. Chretien, O. Chazouilleres and R. Poupon, Demographic, lifestyle, medical and familial factors associated with prim ary biliary cirrhosis, Journal of hepatology 53, 162-169.
28. K. Harada, J. Van de Water, P.S. Leung et al., In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis: Predominance of the th1 subset, Hepatology (Baltimore, Md 25 (1997), 791-796. (Pubitemid 27157116)
29. C.O. Zein, K. Beatty, A.B. Post, L. Logan, S. Debanne and A.J. McCullough, Smoking and increased severity of hepatic fibrosis in primary biliary cirrhosis: A cross validated retrospective assessment, Hepatology (Baltimore, Md 44 (2006), 1564-1571. (Pubitemid 44953661)
30. J. McDermid, M. Chen, Y. Li et al., Reverse transcriptase activity in patients with primary biliary cirrhosis and other autoimmune liver disorders, Alimentary Pharmacology & Therapeutics 26 (2007), 587-595. (Pubitemid 47174287)
31. J.Van deWater, H. Ishibashi, R.L.Coppel andM.E.Gershwin, Molecular mimicry and primary biliary cirrhosis: Premises not promises, Hepatology (Baltimore, Md 33 (2001), 771-775. (Pubitemid 32246623)
32. S. Shimoda, M. Nakamura, H. Shigematsu et al., Mimicry peptides of human pdce2 163176 peptide, the immunodominant tcell epitope of primary biliary cirrhosis, Hepatology (Baltimore, Md 31 (2000), 1212-1216. (Pubitemid 30351280)
33. U. Hopf, B. Moller, R. Stemerowicz et al., Relation between escherichia coli r(rough)forms in gut, lipid a in liver, and primary biliary cirrhosis, Lancet 2 (1989), 1419-1422. (Pubitemid 20012059)
34. H. Miyakawa, A. Tanaka, C. Selmi et al., Serum reactivity against bacterial pyruvate dehydrogenase: Increasing the specificity of antimitochondrial antibodies for the diagnosis of primary biliary cirrhosis, Clinical & Developmental Immunology 13 (2006), 289-294. (Pubitemid 44950044)
35. H. Tanimoto, S. Shimoda, M. Nakamura et al., Promiscuous t cells selected by escherichia coli: Ogdce2 in primary biliary cirrhosis, Journal of Autoimmunity 20 (2003), 255-263. (Pubitemid 36561491)
36. L. Vilagut, A. Pares, O. Vinas, J. Vila, M.T. Jimenez de Anta and J. Rodes, Antibodies to mycobacterial 65kd heat shock protein crossreact with the main mitochondrial antigens in patients with primary biliary cirrhosis, European Journal of Clinical Investigation 27 (1997), 667-672. (Pubitemid 27368297)
37. R.Klein,M.Wiebel, S. Engelhart and P.A.Berg, Sera frompatients with tuberculosis recognize the m2aepitope (e2subunit of pyruvate dehydrogenase) specific for primary biliary cirrhosis, Clinical and Experimental Immunology 92 (1993), 308-316. (Pubitemid 23151043)
38. A. Tanaka, T.P. Prindiville, R.Gish et al., Are infectious agents involved in primary biliary cirrhosis? A pcr approach, Journal of Hepatology 31 (1999), 664-671. (Pubitemid 29487688)
39. J. O-Donohue, B. McFarlane, A. Bomford, M. Yates and R. Williams, Antibodies to atypical mycobacteria in primary biliary cirrhosis, Journal of Hepatology 21 (1994), 887-889. (Pubitemid 24374160)
40. C. Selmi, D.L. Balkwill, P. Invernizzi et al., Patients with primary biliary cirrhosis react against a ubiquitous xenobioticmetabolizing bacterium, Hepatology (Baltimore, Md 38 (2003), 1250-1257. (Pubitemid 37314834)
41. K.A. Padgett, C. Selmi, T.P. Kenny et al., Phylogenetic and immunological definition of four lipoylated proteins from novosphingobium aromaticivorans, implications for primary biliary cirrhosis, Journal of Autoimmunity 24 (2005), 209-219. (Pubitemid 40545883)
42. J. Mattner, P.B. Savage, P. Leung et al., Liver autoimmunity triggered by microbial activation of natural killer t cells, Cell host & Microbe 3 (2008), 304-315. (Pubitemid 351637431)
43. P.S. Leung, O. Park, S. Matsumura, A.A. Ansari, R.L. Coppel and M.E. Gershwin, Is there a relation between Chlamydia infection and primary biliary cirrhosis?, Clinical & Developmental Immunology 10 (2003), 227-233. (Pubitemid 38089415)
44. A.S. Abdulkarim, L.M. Petrovic, W.R. Kim, P. Angulo, R.V. Lloyd and K.D. Lindor, Primary biliary cirrhosis: An infectious disease caused by chlamydia pneumoniae?, Journal of Hepatology 40 (2004), 380-384. (Pubitemid 38230836)
45. K. Dohmen, H. Shigematsu, Y. Miyamoto, F. Yamasaki, K. Irie and H. Ishibashi, Atrophic corpus gastritis and helicobacter pylori infection in primary biliary cirrhosis, Digestive Diseases and Sciences 47 (2002), 162-169. (Pubitemid 34075034)
46. D. Bogdanos, T. Pusl, C. Rust, D. Vergani and U. Beuers, Primary biliary cirrhosis following lactobacillus vaccination for recurrent vaginitis, Journal of Hepatology 49 (2008), 466-473.
47. D. TaylorRobinson, A.W. Sharif, N.S. Dhanjal and S.D. TaylorRobinson, Chlamydia pneumoniae infection is an unlikely cause of primary biliary cirrhosis, Journal of Hepatology 42 (2005), 779-780.
48. D.P. Bogdanos, H. Baum, A. Grasso et al., Microbial mimics aremajor targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis, Journal of Hepatology 40 (2004), 31-39. (Pubitemid 38064710)
49. M. Durazzo, F. Rosina, A. Premoli et al., Lack of association between seroprevalence of helicobacter pylori infection and primary biliary cirrhosis, World J Gastroenterol 10 (2004), 3179-3181. (Pubitemid 39419883)
50. S.Y. Boomkens, S. de Rave, R.G. Pot et al., The role of helicobacter spp In the pathogenesis of primary biliary cirrhosis and primary sclerosing cholangitis, FEMS Immunology and Medical Microbiology 44 (2005), 221-225. (Pubitemid 41373380)
51. L. Xu, Z. Shen, L. Guo et al., Does a betaretrovirus infection trigger primary biliary cirrhosis? Proceedings of The National Academy of Sciences of The United States of America 100 (2003), 8454-8459. (Pubitemid 36842566)
52. C. Selmi, S.R. Ross,A.A.Ansari et al., Lack of immunological or molecular evidence for a role of mouse mammary tumor retrovirus in primary biliary cirrhosis, Gastroenterology 127 (2004), 493-501. (Pubitemid 39091898)
53. H. Johal, G.M. Scott, R. Jones, C. Camaris, S. Riordan and W.D.. Rawlinson, Mouse mammary tumour viruslike virus (mmtvlv) is present within the liver in a wide range of hepatic disorders and unrelated to nuclear p53 expression or hepatocarcinogenesis, Journal of Hepatology 50 (2009), 548-554.
54. A.L. Mason, K.D. Lindor, B.R. Bacon, C. Vincent, J.M. Neuberger and S.T. Wasilenko, Clinical trial: Randomized controlled trial of zidovudine and lamivudine for patients with primary biliary cirrhosis stabilized on ursodiol, Alimentary Pharmacology & Therapeutics (2008).
55. J. Irie, Y.Wu, L.S.Wicker et al., NodC3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis, The Journal of Experimental Medicine 203 (2006), 1209-1219. (Pubitemid 43736591)
56. M. Chen, D. Graham, G. Zhang, S.Wasilenko, C. McDougall and M. Kneteman, Biliary infection with mouse mammary tumor virus in the nodC3c4 mouse and other mouse models of primary biliary cirrhosis, Hepatology (Baltimore, Md 46 (2007), 551A.
57. B. Subsin,M. Chen, S.Girgis andA.Mason,Mousemammary tumor virus triggers viral cholangitis in the nodC3c4 mouse model of primary biliary cirrhosis, Hepatology (Baltimore, Md 50 (2009), 998A.
58. C. Scheidereit, D. von der Ahe, A.C. Cato et al., ProteinDNA interactions at steroid hormone regulated genes, Endocrine Research 15 (1989), 417-440. (Pubitemid 20087078)
59. A.K. Burroughs, I.J. Rosenstein, O. Epstein, J.M. HamiltonMiller, W. Brumfitt and S. Sherlock, Bacteriuria and primary biliary cirrhosis, Gut 25 (1984), 133-137. (Pubitemid 14131405)
60. J. Van de Water, J. Turchany, P.S. Leung et al., Molecular mimicry in primary biliary cirrhosis Evidence for biliary epithelial expression of a molecule crossreactive with pyruvate dehydrogenase complexe2, The Journal of Clinical Investigation 91 (1993), 2653-2664. (Pubitemid 23182520)
61. D. Howel, C.M. Fischbacher, R.S. Bhopal, J. Gray, J.V. Metcalf and O.F. James, An exploratory populationbased casecontrol study of primary biliary cirrhosis, Hepatology (Baltimore, Md 31 (2000), 1055-1060. (Pubitemid 30233228)
62. E.I. Rigopoulou, S.P. Georgiadou, S. Barbanis and G.N. Dalekos, Lack of association between appendectomy and primary biliary cirrhosis, Scandinavian Journal ofGastroenterology 41 (2006), 573-576.
63. M. Ehlers and J.V. Ravetch, Opposing effects of tolllike receptor stimulation induce autoimmunity or tolerance, Trends in Immunology 28 (2007), 74-79. (Pubitemid 46176735)
64. S. Agrawal and E.R. Kandimalla, Modulation of tolllike receptor 9 responses through synthetic immunostimulatory motifs of DNA, Annals of The New York Academy of Sciences 1002 (2003), 30-42. (Pubitemid 38253327)
65. Y. Moritoki, Z.X. Lian, H. Wulff et al., AMA production in primary biliary cirrhosis is promoted by the TLR9 ligand CpG and suppressed by potassium channel blockers, Hepatology (Baltimore, Md 45 (2007), 314-322. (Pubitemid 46374588)
66. T.K. Mao, Z.X. Lian, C. Selmi et al., Altered monocyte responses to defined TLRligands in patientswith primary biliary cirrhosis, Hepatology (Baltimore, Md 42 (2005), 802-808. (Pubitemid 41401117)
67. A.J. Stellon and R.Williams, Increased incidence of menstrual abnormalities and hysterectomy preceding primary biliary cirrhosis, British Medical Journal (Clinical Research Ed 293 (1986), 297-298. (Pubitemid 16070826)
68. K.V.Menon, P.Angulo, G.M. Boe andK.D. Lindor, Safety and efficacy of estrogen therapy in preventing bone loss in primary biliary cirrhosis, The American Journal of gastroenterology 98 (2003), 889-892. (Pubitemid 36576319)
69. D. Alvaro, P. Invernizzi, P. Onori et al., Estrogen receptors in cholangiocytes and the progression of primary biliary cirrhosis, Journal of Hepatology 41 (2004), 905-912. (Pubitemid 39575656)
70. D. Alvaro, P. Onori, V.D.Metalli et al., Intracellular pathways mediating estrogeninduced cholangiocyte proliferation in the rat, Hepatology (Baltimore, Md 36 (2002), 297-304. (Pubitemid 34810348)
71. C. Selmi, C.A. Cocchi, M. Zuin and M.E. Gershwin, The chemical pathway to primary biliary cirrhosis, Clinical Reviews in Allergy & Immunology 36 (2009), 23-29.
72. P. Griem, M. Wulferink, B. Sachs, J.B. Gonzalez and E. Gleichmann, Allergic and autoimmune reactions to xenobiotics: How do they arise? Immunology Today 19 (1998), 133-141. (Pubitemid 28194660)
73. P.S. Leung, C. Quan, O. Park et al., Immunization with a xenobiotic 6bromohexanoate bovine serum albumin conjugate induces antimitochondrial antibodies, J Immunol 170 (2003), 5326-5332. (Pubitemid 36554768)
74. P. Invernizzi, C. Selmi andM.E.Gershwin, Update on primary biliary cirrhosis, Dig Liver Dis 42, 401-408.
75. K. Amano, P.S. Leung, Q. Xu et al., Xenobioticinduced loss of tolerance in rabbits to the mitochondrial autoantigen of primary biliary cirrhosis is reversible, J Immunol 172 (2004), 6444-6452. (Pubitemid 38621254)
76. H.R. Walden, J.A. Kirby, S.J. Yeaman, J. Gray, D.E. Jones and J.M. Palmer, Xenobiotic incorporation into pyruvate dehydrogenase complex can occur via the exogenous lipoylation pathway, Hepatology (Baltimore, Md 48 (2008), 1874-1884.
77. P.S. Leung, O. Park, K. Tsuneyama et al., Induction of primary biliary cirrhosis in guinea pigs following chemical xenobiotic immunization, J Immunol 179 (2007), 2651-2657.
78. K.Wakabayashi, Z.X. Lian, P.S. Leung et al., Loss of tolerance in c57bl/6 mice to the autoantigen e2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease, Hepatology (Baltimore, Md 48 (2008), 531-540.
79. K. Wakabayashi, K. Yoshida, P.S. Leung et al., Induction of autoimmune cholangitis in nonobese diabetic (nod)1101mice following a chemical xenobiotic immunization, Clinical and Experimental Immunology 155 (2009), 577-586.
80. K. Amano, P.S. Leung, R. Rieger et al., Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: Identification of antibodies against a common environmental, cosmetic, and food additive, 2octynoic acid, J Immunol 174 (2005), 5874-5883. (Pubitemid 40593233)
81. R. Rieger, P.S. Leung,M.R. Jeddeloh et al., Identification of 2nonynoic acid, a cosmetic component, as a potential trigger of primary biliary cirrhosis, Journal of Autoimmunity 27 (2006), 7-16. (Pubitemid 44279362)
82. P.R. Mills, P. Boyle, E.M. Quigley et al., Primary biliary cirrhosis: An increased incidence of extrahepatic malignancies?, Journal of clinical pathology 35 (1982), 541-543. (Pubitemid 12116766)
83. A. Floreani, M.R. Biagini, M. Chiaramonte, S. Milani, C. Surrenti and R. Naccarato, Incidence of hepatic and extrahepatic malignancies in primary biliary cirrhosis (PBC), The Italian Journal of Gastroenterology 25 (1993), 473-476. (Pubitemid 24022941)